60 related articles for article (PubMed ID: 9216701)
1. A case of malignant schwannoma with overexpression of multidrug resistance gene (MDR1) after chemotherapy.
Suto R; Abe Y; Lee YH; Ueyama Y; Yamazaki H; Kijima H; Hiraoka N; Fukuda H; Tamaoki N; Nakamura M
Anticancer Res; 1997; 17(3C):2273-7. PubMed ID: 9216701
[TBL] [Abstract][Full Text] [Related]
2. Expression of the human multidrug resistance gene (MDR1) and prognostic correlation in human osteogenic sarcoma.
Imanishi T; Abe Y; Suto R; Higaki S; Ueyama Y; Nakamura M; Tamaoki N; Fukuda H; Imai N
Tokai J Exp Clin Med; 1994 Sep; 19(1-2):39-46. PubMed ID: 7660382
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistance gene and P-glycoprotein expression in anaplastic carcinoma of the thyroid.
Yamashita T; Watanabe M; Onodera M; Shimaoka K; Ito K; Fujimoto Y; Itoyama S; Sugawara I
Cancer Detect Prev; 1994; 18(5):407-13. PubMed ID: 7812988
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance mediated by overexpression of P-glycoprotein in human osteosarcoma in vivo.
Suto R; Abe Y; Nakamura M; Ohnishi Y; Yoshimura M; Lee YH; Imanishi T; Yamazaki H; Kijima H; Tokunaga T; Oshika Y; Hiraoka N; Tamaoki N; Fukuda H; Ueyama Y
Int J Oncol; 1998 Feb; 12(2):287-91. PubMed ID: 9458350
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance and malignancy in human osteosarcoma.
Scotlandi K; Serra M; Nicoletti G; Vaccari M; Manara MC; Nini G; Landuzzi L; Colacci A; Bacci G; Bertoni F; Picci P; Campanacci M; Baldini N
Cancer Res; 1996 May; 56(10):2434-9. PubMed ID: 8625324
[TBL] [Abstract][Full Text] [Related]
6. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
7. Inhibition growth of multidrug resistant KBV200 cells by MDR1 antisense RNA.
Li Y; Wang Y
Biochem Biophys Res Commun; 1997 Oct; 239(1):345-8. PubMed ID: 9345322
[TBL] [Abstract][Full Text] [Related]
8. Association of mdr1 gene expression with other prognostic factors and clinical outcome in human breast cancer.
Punyammalee B; Manoromana S; Purisa W; Chariyalertsak S; Rerkamnuaychok B
J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S162-73. PubMed ID: 9347665
[TBL] [Abstract][Full Text] [Related]
9. Rapid activation of MDR1 gene expression in human metastatic sarcoma after in vivo exposure to doxorubicin.
Abolhoda A; Wilson AE; Ross H; Danenberg PV; Burt M; Scotto KW
Clin Cancer Res; 1999 Nov; 5(11):3352-6. PubMed ID: 10589744
[TBL] [Abstract][Full Text] [Related]
10. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
[TBL] [Abstract][Full Text] [Related]
11. Effects of celecoxib on the reversal of multidrug resistance in human gastric carcinoma by downregulation of the expression and activity of P-glycoprotein.
Huang L; Wang C; Zheng W; Liu R; Yang J; Tang C
Anticancer Drugs; 2007 Oct; 18(9):1075-80. PubMed ID: 17704658
[TBL] [Abstract][Full Text] [Related]
12. Cytokine-induced killer cells showing multidrug resistance and remaining cytotoxic activity to tumor cells after transfected with mdr1 cDNA.
Li HF; Yang YH; Shi YJ; Wang YQ; Zhu P
Chin Med J (Engl); 2004 Sep; 117(9):1348-52. PubMed ID: 15377427
[TBL] [Abstract][Full Text] [Related]
13. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y
Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441
[TBL] [Abstract][Full Text] [Related]
14. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
[TBL] [Abstract][Full Text] [Related]
15. Retroviral coexpression of two different types of drug resistance genes to protect normal cells from combination chemotherapy.
Suzuki M; Sugimoto Y; Tsukahara S; Okochi E; Gottesman MM; Tsuruo T
Clin Cancer Res; 1997 Jun; 3(6):947-54. PubMed ID: 9815770
[TBL] [Abstract][Full Text] [Related]
16. Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia.
Efferth T; Sauerbrey A; Steinbach D; Gebhart E; Drexler HG; Miyachi H; Chitambar CR; Becker CM; Zintl F; Humeny A
Int J Oncol; 2003 Aug; 23(2):509-17. PubMed ID: 12851703
[TBL] [Abstract][Full Text] [Related]
17. MDR1 gene expression in primary and advanced breast cancer.
Yang X; Uziely B; Groshen S; Lukas J; Israel V; Russell C; Dunnington G; Formenti S; Muggia F; Press MF
Lab Invest; 1999 Mar; 79(3):271-80. PubMed ID: 10092063
[TBL] [Abstract][Full Text] [Related]
18. Drug resistance in chemotherapy for breast cancer.
Saeki T; Tsuruo T; Sato W; Nishikawsa K
Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():84-9. PubMed ID: 16273361
[TBL] [Abstract][Full Text] [Related]
19. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
Ramachandran C; Wellham LL
Anticancer Res; 2003; 23(3B):2681-90. PubMed ID: 12894558
[TBL] [Abstract][Full Text] [Related]
20. A case of pulmonary adenocarcinoma with overexpression of multidrug resistance-associated protein and p53 aberration.
Nakamura M; Abe Y; Katoh Y; Oshika Y; Hatanaka H; Tsuchida T; Yamazaki H; Kijima H; Inoue H; Ueyama Y
Anticancer Res; 2000; 20(3B):1921-5. PubMed ID: 10928127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
